Silo Pharma shareholders approve reincorporation from Delaware to Nevada

Silo Pharma, Inc.

Proposal 3 approved with 1,589,197 For, 43,858 Against, 10,276 Abstain, 40,875 Broker Non-Vote.
Reincorporation from Delaware to Nevada was the sole item voted on at reconvened 2023 annual meeting.
Record date October 12, 2023; 3,109,497 shares outstanding; quorum was present.
Effective date of reincorporation not disclosed in filing.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Silo Pharma, Inc. shareholders approved Reincorporation from the State of Delaware to the State of Nevada at the 2023-12-11 meeting.

Outcome: passed
Meeting: 2023-12-11

Exact text from the filing

The result of the votes to approve the Reincorporation was as follows: . For Against Abstain Broker Non-Vote 1,589,197 43,858 10,276 40,875

View on SEC.gov

Browse all shareholder votes →

Silo Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-094712

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.